Correlation Between SAB Biotherapeutics and Forte Biosciences
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Forte Biosciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Forte Biosciences.
Diversification Opportunities for SAB Biotherapeutics and Forte Biosciences
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between SAB and Forte is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Forte Biosciences go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Forte Biosciences
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 15.39 times more return on investment than Forte Biosciences. However, SAB Biotherapeutics is 15.39 times more volatile than Forte Biosciences. It trades about 0.15 of its potential returns per unit of risk. Forte Biosciences is currently generating about 0.05 per unit of risk. If you would invest 4.61 in SAB Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 2.69 from holding SAB Biotherapeutics or generate 58.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 73.49% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Forte Biosciences
Performance |
| Timeline |
| SAB Biotherapeutics |
| Forte Biosciences |
SAB Biotherapeutics and Forte Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Forte Biosciences
The main advantage of trading using opposite SAB Biotherapeutics and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Forte Biosciences vs. Eliem Therapeutics | Forte Biosciences vs. HCW Biologics | Forte Biosciences vs. Scpharmaceuticals | Forte Biosciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |